{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T02:42:47Z","timestamp":1774665767118,"version":"3.50.1"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1985,1,1]],"date-time":"1985-01-01T00:00:00Z","timestamp":473385600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[1985]]},"DOI":"10.1007\/bf00544087","type":"journal-article","created":{"date-parts":[[2004,11,19]],"date-time":"2004-11-19T08:54:28Z","timestamp":1100854468000},"page":"313-318","source":"Crossref","is-referenced-by-count":19,"title":["Follow-up study of enzymuria and ? 2 microglobulinuria during cis-platinum treatment"],"prefix":"10.1007","volume":"29","author":[{"given":"A. S.","family":"Tirelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cavanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Mangioni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B. M.","family":"Assael","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/B978-0-12-565050-2.50016-4","volume-title":"Cisplatin","author":"K Harrap","year":"1980","unstructured":"Harrap K, Jones M, Ray Wilkinson C et al. (1980) In: Prestayko AW et al. (eds) Cisplatin. Academic Press, New York, pp 193?212"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1002\/1097-0142(197704)39:4<1362::AID-CNCR2820390403>3.0.CO;2-N","volume":"39","author":"JC Gonzales-Vitale","year":"1977","unstructured":"Gonzales-Vitale JC, Hayes DM, Cvitkovic E, Sternberg S (1977) Renal pathology in clinical trials of cis-platinum (II) diamminedichloride. Cancer 39: 1362?1371","journal-title":"Cancer"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0002-9378(16)32638-2","volume":"141","author":"DJ Hall","year":"1981","unstructured":"Hall DJ, Diasio R, Goplerud DR (1981) Cis-platinum in gynecologic cancer. III Toxicity. Am J Obstet Gynecol 141: 309?312","journal-title":"Am J Obstet Gynecol"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"628","DOI":"10.7326\/0003-4819-95-5-628","volume":"95","author":"JD Blachley","year":"1981","unstructured":"Blachley JD, Hill JB (1981) Renal and electrolyte disturbances associated with cisplatin. Ann Intern Med 95: 628?632","journal-title":"Ann Intern Med"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/B978-0-12-565050-2.50040-1","volume-title":"Cisplatin","author":"RL Comis","year":"1980","unstructured":"Comis RL (1980) In: Prestayko AW et al. (eds) Cisplatin. Academic Press New York pp 485?494"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1002\/1097-0142(197704)39:4<1372::AID-CNCR2820390404>3.0.CO;2-J","volume":"39","author":"DM Hayes","year":"1977","unstructured":"Hayes DM, Cvitkovic E, Golbey RB et al. (1977) High dose cis-platinum diamminedichloride. Amelioration of renal toxicity by mannitol diuresis. Cancer 39: 1372?1381","journal-title":"Cancer"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/1097-0142(19800101)45:1<11::AID-CNCR2820450104>3.0.CO;2-E","volume":"45","author":"SE Vogl","year":"1980","unstructured":"Vogl SE, Zaravinos T, Kaplan BH (1980) Toxicity of cisdiamminedichloroplatinum II given in a two-hour outpatient regimen of diuresis and hydration. Cancer 45: 11?15","journal-title":"Cancer"},{"key":"CR8","first-page":"1475","volume":"63","author":"AM Guarino","year":"1979","unstructured":"Guarino AM, Miller DS, Arnold ST, Pritchard JB et al. (1979) Platinate toxicity: Past, present and prospects. Cancer Treat Rep 63: 1475?1483","journal-title":"Cancer Treat Rep"},{"key":"CR9","first-page":"397","volume":"44","author":"DD Choie","year":"1981","unstructured":"Choie DD, Longnecker DS, Del Campo AA (1981) Acute and chronic cisplatin nephropathy in rats. Lab Invest 44: 397?402","journal-title":"Lab Invest"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1038\/bjc.1982.45","volume":"45","author":"CJ Kovacs","year":"1982","unstructured":"Kovacs CJ, Braunschweiger PG, Schenken LL, Burholt DR (1982) Proliferative defects in renal and intestinal epithelium after cis-diamminedichloroplatinum (II). Br J Cancer 45: 286?294","journal-title":"Br J Cancer"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0009-8981(81)90373-9","volume":"112","author":"U Diener","year":"1981","unstructured":"Diener U, Knoll E, Langer B, Rautenstrauch H, Ratge D, Wisser H (1981) Urinary excretion of N-acetyl-?-D-glucosaminidase in patients receiving amikacin or cisplatinum. Clin Chim Acta 112: 149?157","journal-title":"Clin Chim Acta"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1038\/clpt.1980.79","volume":"27","author":"BR Jones","year":"1980","unstructured":"Jones BR, Ravi B, Bhalla BS, Mladek J, Kaleya RN et al. (1980) Comparison of methods of evaluating nephrotoxicity of cis-platinum. Clin Pharmacol Ther 27: 557?562","journal-title":"Clin Pharmacol Ther"},{"key":"CR13","first-page":"1083","volume":"65","author":"AI Cohen","year":"1981","unstructured":"Cohen AI, Harberg J, Citrin DL (1981) Measurement of urinary ? 2 microglobulin in the detection of cisplatin nephrotoxicity. Cancer Treat Rep 65: 1083?1085","journal-title":"Cancer Treat Rep"},{"key":"CR14","first-page":"1083","volume":"64","author":"JA Kuhn","year":"1980","unstructured":"Kuhn JA, Argy WP, Rakowski TA et al. (1980) Nephrotoxicity of cis-diamminedichloroplatinum (II) as measured by urinary ?-glucorinidase. Cancer Treat Rep 64: 1083?1086","journal-title":"Cancer Treat Rep"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1042\/bj0780151","volume":"78","author":"H Leaback","year":"1961","unstructured":"Leaback H, Walker PG (1961) Studies on glucosaminidase: IV. The fluorimetric assay of N-acetyl-?-glucosaminidase. Biochem J 78: 151?156","journal-title":"Biochem J"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"99","DOI":"10.3181\/00379727-160-40397","volume":"160","author":"DN Gilbert","year":"1979","unstructured":"Gilbert DN, Houghton DC, Bennet WM, Plamp CE, Reger K, Porter GA (1979) Reversibility of gentamicin nephrotoxicity in rat: Recovery during continous drug administration. Proc Soc Exp Biol Med 160: 99?103","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1128\/AAC.14.3.284","volume":"3","author":"FC Luft","year":"1978","unstructured":"Luft FC, Rankin LI, Sloan RS (1978) Recovery from Aminoglycoside nephrotoxicity with continued drug administration. Antimicrob Agents Chemother 3: 284?287","journal-title":"Antimicrob Agents Chemother"},{"key":"CR18","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3109\/00365517109095721","volume":"28","author":"PE Evrin","year":"1971","unstructured":"Evrin PE, Peterson PA, Wide L, Berggard J (1971) Radio-immunoassay of ? 2 microglobulin in human biological fluids Scand J Clin Lab Invest 28: 439?444","journal-title":"Scand J Clin Lab Invest"},{"key":"CR19","volume-title":"Experimental design procedures for the behavioral sciences","author":"E Roger","year":"1968","unstructured":"Roger E, Kirk A (1968) Experimental design procedures for the behavioral sciences. Brooks\/Cole Publishing Company, Belmont California"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00544087.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00544087\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00544087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,4]],"date-time":"2019-04-04T18:36:04Z","timestamp":1554402964000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00544087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1985]]}},"alternative-id":["BF00544087"],"URL":"https:\/\/doi.org\/10.1007\/bf00544087","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985]]}}}